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Introduction: Based on previously published case reports demonstrating dynamic left intraventricular obstruction
(IVO) triggered by hypovolemia or catecholamines, this study aimed to establish: (1) IVO occurrence in septic shock
patients; (2) correlation between the intraventricular gradient and volume status and fluid responsiveness; and (3)
mortality rate.
Method: We prospectively analyzed patients with septic shock admitted to a general ICU over a 28-month period who
presented Doppler signs of IVO. Clinical characteristics and hemodynamic parameters as well as echocardiographic data
regarding left ventricular function, size, and calculated mass, and left ventricular outflow Doppler pattern and velocity
before and after fluid infusions were recorded.
Results: During the study period, 218 patients with septic shock were admitted to our ICU. IVO was observed in 47 (22 %)
patients. Mortality rate at 28 days was found to be higher in patients with than in patients without IVO (55 % versus 33 %,
p < 0.01). Small, hypercontractile left ventricles (end-diastolic left ventricular surface 4.7 ± 2.1 cm2/m2 and ejection fraction
82 ± 12 %), and frequent pseudohypertrophy were found in these patients. A rise ≥12 % in stroke index was found in
87 % of patients with IVO, with a drop of 47 % in IVO after fluid infusion.
Conclusion: Left IVO is a frequent event in septic shock patients with an important correlation with fluid responsiveness.
The mortality rate was found to be higher in these patients in comparison with patients without obstruction.Introduction
Left intraventricular flow obstruction (IVO) is classically de-
scribed in asymmetric hypertrophic cardiomyopathy [1, 2]
and is characterized by a saber-shaped Doppler flow curve,
with late acceleration [3]. The obstruction is usually at the
level of the left ventricular outflow tract (LVOT), and is due
to systolic anterior movement (SAM) of the anterior leaflet
of the mitral valve. This phenomenon has also been previ-
ously described in certain clinical situations outside the
setting of hypertrophic cardiomyopathy, mainly revolving
around hypovolemia and catecholamine exposure [4–12].
On the other hand, the early phase of septic shock is associ-
ated with hypovolemia, hyperkinesia and low left ventricular
(LV) afterload (making catecholamine infusion necessary),* Correspondence: Slama.michel@chu-amiens.fr
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IVO. Nevertheless, there has been no previous study of the
incidence of left ventricular obstruction in septic shock, or
of the fluid responsiveness of patients presenting with
this obstructive flow pattern. Furthermore, clinical conse-
quences of this obstruction have not been analyzed.
The objective of this prospective study was thus to
gather information prospectively about the prevalence and
clinical implications of this kind of flow pattern (IVO) in
the septic shock patients admitted to our ICU.
Methods
Patients
It is standard practice in our unit to perform an echocar-
diographic assessment of hemodynamically unstable pa-
tients. All examinations are performed by one of three
trained staff members and imaging is repeated at all ther-
apy changes, and after every 500 ml of fluid loading inarticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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interest in the phenomena, during the 28-month period
from April 2008 to October 2010, whenever a patient’s
echocardiogram suggested an IVO obstruction (peak vel-
ocity LVOT ≥0.9 m/s), we prospectively stored all their
two-dimensional images and Doppler curves in a desig-
nated patient file for later review or retrieval, and docu-
mented the clinical information documented on the
medical records and ICU observation charts for the same
date and time. All echocardiographic examinations were
performed during the first 6 hours following admission to
the ICU and all septic shock patients had an echocardio-
graphic study. This information included demographic data
(such as age, sex, diagnosis, Simplified Acute Physiology
Score (SAPS) II, presence of mechanical ventilation, ICU
stay, ICU mortality, and mortality at 28 days), as well as
physiological variables (such as heart rate, systolic blood
pressure, diastolic blood pressure, mean arterial pressure,
pulse pressure, pulse pressure variations, catecholamine use
and dose, hemodialysis), and ventilator parameters (such as
presence of mechanical ventilation and tidal volume).
We analyzed baseline characteristics and mortality of
all patients with septic shock without IVO hospitalized
during the same period. All patients in this group had
an early echocardiography examination that allowed us
to rule out IVO; however, images were not stored for pa-
tients without obstruction and therefore were unavail-
able for complete analysis in this study.
This study was approved by the ethics committee of
Rouen hospital, and the research committee waived con-
sent due to the observational nature of the study.
Echocardiography data
From the patients’ echocardiography examinations we col-
lected information regarding left ventricular (LV) size and
function. From the parasternal long axis view using
M-mode we measured the left ventricular end-diastolic
diameter (LVEDD), and septal (S) and posterior (P) wall
thickness. From the parasternal short axis view we mea-
sured the LV area in diastole and in systole and then we
calculated the shortening fractional area. LV mass was
calculated using the formula 0.8 × (1.04 × (LVEDD + S +
P)3 – LVEDD3) – 13.6 g. LV mass was considered normal if
<115 g/m2 in males and <115 g/m2 in females. Pseudohy-
pertrophy was defined as LV wall thickness ≥12 mm with a
normal calculated LV mass. Inferior vena cava diameter
was obtained from a subcostal view, mitral flow velocities
(E and A wave) using pulsed Doppler from an apical four-
chambers view, annulus velocities (E’ and A’) from an apical
four-chambers view using tissue Doppler imaging, as well
as LV outflow Doppler data (velocity and curve morph-
ology) in patients with IVO using continuous wave Dop-
pler. The location of IVO was analyzed and found at the
level of the LVOT or at the level of the midventricle. Weconsidered a mitral regurgitation as moderate or severe if
regurgitant flow width was >6 mm. All these parameters
were recorded during the end-expiratory phase. Cardiac
output was calculated from measurements of aortic annu-
lus measured from the parasternal long axis view and aortic
VTI measured on aortic blood flow recorded using pulsed
Doppler at the level of the aortic annulus from an apical
four-chambers view. Information from each examination
performed before a fluid bolus was compared with data
from the corresponding “after-bolus” examination.
Statistics
All data are presented as mean ± SD. Student's t test was
performed to compare continuous values and chi-squared
test performed for percentages. Analysis of variance for
repeated measurement was used to compare pre- and
postfluid measurements. Statistical significance was de-
fined as a p-value less than 0.05. A Kaplan-Meier survival
curve was done for the mortality rate. Multivariable logis-
tic regression was also performed to analyze the effect of
IVO. The results are shown as odds ratios with 95 % con-
fidence intervals. Two-sided p-values less than 0.05 were
considered statistically significant.
Results
During the 28 month timeframe, 218 septic shock patients
were admitted to the ICU, of which a total of 47 (22 %)
had a documented IVO flow pattern (Fig. 1).
Baseline characteristics
A comparison of the baseline characteristics between the
patients with or without LVO is presented in Table 1. Age,
SAPS II, length of stay, the proportion of males, mechan-
ical ventilation, and the numbers of medical and surgical
patients were similar between both groups. Thirty percent
of patients had a diagnosis of acute respiratory distress
syndrome in both groups with and without IVO.
A total of 47 patients with septic shock with left ven-
tricular obstruction were analyzed. Twenty-seven pa-
tients (57 %) were male. The mean age was 69 ± 11
years (range 37 to 85); the mean SAPS II score [13] was
59 ± 16 (range 30 to 97), and the mean body mass index
was 29 ± 7 kg/m2 (range 16 to 52). Average length of
stay in the ICU was 12 ± 10 days (range 1 to 51).
The cause of sepsis was divided between pneumonia
(51 %), peritonitis (26 %), cellulitis (9 %), urinary infection
(6 %), pericarditis (4 %), endocarditis (2 %) and pancreatitis
(2 %), and was not statistically different in the group of sep-
tic shock patients without obstruction.
Forty three percent of these patients with IVO were on
dialysis. In terms of ventilatory support, 17 % of them were
spontaneously breathing, while 83 % were intubated, on
volume-controlled ventilation or pressure support mode,
with a mean tidal volume of 8 ± 1 ml/kg ideal body weight,
Fig. 1 Flow chart. IVO intraventricular obstruction
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ference was found compared to the group without IVO.
The mean lactate value obtained from records was 3.4 ±
3.5 mmol/l, and all patients were receiving at least one
kind of catecholamine: 13 % of patients were receiving a
dobutamine infusion at a mean dose of 8.8 ± 4.6 μg/kg/
minute, while 83 % were receiving noradrenaline at 1.2 ±
1.6 μg/kg/minute, and 6 % of patients were on an adren-
aline infusion at a rate of 1.1 ± 0.9 μg/kg/minute; thereTable 1 Characteristics of patients with septic shock with and witho
Septic shock patients without IVO (n = 1
Age (years) 62 ± 15
Males 106 (62 %)
SAPS II 54 ± 21
Mechanical ventilation 149 (87 %)
ICU stay duration (days) 11 ± 27
Medical patients 109 (64 %)
Surgical patients 62 (36 %)
ICU mortality 41 (24 %)
Mortality at 28 days 57 (33 %)
Values are shown as n (%) or mean ± SD. IVO intraventricular obstruction, ns not sigwas no significant difference compared to the group with-
out obstruction.
Echocardiographic characteristics of patients with IVO
Transthoracic echocardiography examination was per-
formed using Vivid-I (General Electric (GE), Fairfield,
Connecticut, USA) early after the onset of the septic shock
(2.5 ± 2.7 hours) within the first 6 hours in 31/47 (66 %)
of patients, and the characteristics are shown in Table 2.ut IVO
71) Septic shock patients with IVO (n = 47) p value
69 ± 11 ns
27 (57 %) ns
59 ± 16 ns
39 (83 %) ns
12 ± 10 ns
32 (68 %) ns
15 (32 %) ns
25 (53 %) <0.01
26 (55 %) <0.01
nificant, SAPS Simplified Acute Physiology Score
Table 2 Hemodynamic and echocardiographic characteristics
of patients with intraventricular obstruction before and after
fluid infusion
Before After p value
Heart rate (beats/minute) 109 ± 25 102 ± 22 ns
Systolic arterial pressure (mmHg) 110 ± 28 141 ± 32 <0.01
Diastolic arterial pressure (mmHg) 54 ± 11 65 ± 14 <0.01
Mean arterial pressure (mmHg) 71 ± 16 89 ± 1 <0.01
Cardiac output (l/minute) 4.6 ± 1.9 5.8 ± 2.1 <0.01
Cardiac index (l/minute/m2) 2.4 ± 0.9 3 ± 1 <0.01
Stroke volume (ml) 43 ± 18 58 ± 22 <0.01
Indexed stroke volume (ml/m2) 23 ± 10 31 ± 11 <0.01
Intraventricular obstruction (m/s) 1.9 ± 0.9 1 ± 1 <0.01
Intraventricular obstruction (mmHg) 18 ± 18 8 ± 13 <0.01
Inferior vena cava diameter (mm) 16 ± 6.4 18 ± 6.6 ns
E/A 0.8 ± 0.46 0.9 ± 0.3 ns
E’ (cm/s) 14 ± 5 16 ± 5 ns
E’/A’ 0.77 ± 0.26 0.87 ± 0.37 ns
E/E’ 5.8 ± 2.1 6.8 ± 1.8 ns
A late velocity of diastolic mitral flow, A’ late velocity of diastolic mitral
annulus motion, E early diastolic velocity of mitral flow, E’ early velocity of
diastolic mitral annulus motion, ns not significant
Chauvet et al. Critical Care  (2015) 19:262 Page 4 of 8Position of the intraventricular gradient
An intraventricular gradient (IVG) compatible with a mid-
LV obstruction (Fig. 2) was noted in 17 patients, 11 patients
had LV outflow obstruction, and 19 had both.
SAM of the mitral valve
Thirty one (66 %) patients had a SAM, and in 13 % of these
cases (4/31) it was accompanied by significant mitral regur-
gitation (moderate or severe).
Evidence of hypovolemia
The patients with IVO were found to have small and
hypercontractile left ventricles. End-diastolic LVEDD
diameter was registered in 34 patients (72 %) and was
found to be quite small, with a mean value of 37 ± 9
mm. Measurements of the indexed end-diastolic area of
the left ventricle was also available in 22 patients (47 %)
and had a mean value of 4.7 ± 2.1 cm2/m2. Hypercon-
tractility with a LV ejection fraction (LVEF) ≥70 % was
observed in 45 of the 47 patients (96 %). The mean
LVEF across all 47 patients was 82 ± 12 %.
Small left ventricle and pseudohypertrophy
Though only two patients had previously diagnosed myo-
cardial hypertrophy, 30 patients (64 %) exhibited thick-
ened myocardial walls at the time of the first examination:
20 (43 %) had an end-diastolic posterior wall thickness
≥12 mm, 2 (4 %) had a septal end-diastolic thickness ≥13
mm and 9 (19 %) had a maximum thickness septal bulge≥15 mm. In the majority of these patients (16 cases) we
were able to calculate ventricular mass [14] and found that
in 81 % of them (13 cases) the calculated LV mass was
within the range of normality, despite the apparent thick-
ening, and that, therefore, the wall thickening seen on
two-dimensional echocardiography was actually pseudo-
hypertrophy (Fig. 3).
Pre- and postfluid bolus comparison
The mean IVG velocity prior to a first fluid bolus was 1.9
± 0.9 m/s (Table 2). Postfluid bolus examination showed a
disappearance of the IVG pattern in 17 patients (36 %).
The mean IVG peak velocity after a single 500 ml fluid
bolus was reduced to 1 ± 1 m/s, constituting an average
drop of 0.9 m/s (or 47 %) (p < 0.01) (Fig. 4).
Cardiac index rose from 2.4 ± 0.9 to 3.0 ± 1.0 l/minute
per m2 after fluid administration, thus increasing an
average of 0.6 ± 0.5 l/minute per m2, or 31 ± 31 %, while
the systolic index rose an average 8 ± 5 ml/m2, or 35 %,
from 23 ± 9 to 31 ± 11 ml/m2 (p < 0.01).
Mean arterial pressure rose from 71 ± 16 to 89 ± 20
mmHg, an average increase of 18 ± 20 mmHg (30 %), and
systolic blood pressure rose from 110 ± 28 to 141 ± 32
mmHg (p < 0.01). Heart rate dropped from 109 ± 25 to
102 ± 22 beats/minute, constituting a mean drop of 8 ±
14 beats/minute (5 %) after a single 500 ml fluid challenge
(not significant).
Fluid-responsiveness of patients with IVO
Thirty five of the 47 patients (79 %) had an increase ≥12 %
in cardiac index; 40 patients (87 %) had an increase
greater than 12 % in their stroke index (SI). Ninety eight
percent of patients presented at least a 10 % rise in SI, and
all patients increased their SI after volume infusion.
Mortality
ICU mortality (Table 1) was statistically higher in the
group of septic shock patients with LV obstruction when
compared with patients without obstruction (25/47 (53
%) versus 41/171 (24 %), p < 0.01)) as was the mortality
at 28 days (26/47 (55 %) versus 57/171 (33 %), p < 0.01).
In multivariate analysis, compared to patients without
IVO, the patients with IVO had an increased 28-day
mortality (odds ratio 2.23, 95 % confidence interval
1.08–4.58, p = 0.03) and ICU mortality (odds ratio 3.77,
95 % confidence interval 1.77–8.03, p = 0.001) after
adjusting for SAPS II (Table 3).
Discussion
In this prospective study, IVO was seen in 22 % of patients
with septic shock admitted to the ICU over the 18-month
period studied.
The presence of IVO is associated with a high mortality
rate. The data showed an association between the presence
Fig. 2 Left intraventricular obstruction. a Pulsed-wave Doppler curve showing the characteristic late peaking saber-shape indicating a LV outflow
obstruction (IVG). b After fluid replacement, the flow profile returns to normal symmetrical shape
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presence of hypovolemia and cardiac hypercontractility,
and also demonstrated that these patients frequently
present with small and pseudohypertrophic left ventricles.
Furthermore, this study also demonstrates the high rate of
fluid responsiveness in these patients with IVO despite the
absence of significant pulse pressure variations.
Dynamic obstruction at the level of the LVOT was
classically described in patients with congenital asym-
metric left ventricular hypertrophy (LVH) [1–3], and is
physiopathologically explained by a systolic narrowing of
the LVOT creating a Venturi effect. This obstruction isFig. 3 Pseudohypertrophy. Echocardiography in the parasternal short axis v
ages, despite LV mass being unchanged. a The reduction in LVEDD size of
in systole (“kissing” walls)usually associated with SAM of the anterior leaflet of the
mitral valve into the LVOT [2, 4]. IVO is not limited to
the classic septal hypertrophy and may also be seen in
other congenital cardiomyopathies with mid-ventricular
or apical hypertrophy [15, 16]. IVO has also been dem-
onstrated in patients with concentric hypertrophy, such
as that seen in poorly controlled arterial hypertension.
Furthermore, some patients with LVH may have a latent
(subclinical) obstruction which can be precipitated by
hypovolemia, stress or by the administration of exogen-
ous catecholamines such as adrenaline, noradrenaline or
dobutamine, all of which may disturb this delicateiew. Ventricular wall appear thickened in these two-dimensional im-
the left ventricle (LV). b The near obliteration of the ventricular lumen
Fig. 4 Pre- and postfluid bolus comparison. Comparison of
intraventricular obstruction gradient before and after a single 500
ml fluid bolus; points correspond to mean values and error bars to
two standard errors of the mean. The difference before and after
volume expansion was statistically different (p = 0.001)
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scribed in situations of impairment of apical contractility
and relative basal hypercontractility, such as anterior
wall infarcts or the apical ballooning syndrome, a condi-
tion in which high catecholamine levels are also impli-
cated [8, 15, 17, 18]. Dynamic IVO may also appear in
the postoperative setting, notably after aortic stenosis re-
pair, or even after mitral valve repair, if the position of
the mitral prosthesis anatomically interferes with the
LVOT [19, 20]. Furthermore, several case reports illus-
trated that, even in the absence of LVH, obstruction can
also develop in patients with acute intravascular fluid de-
pletion or bleeding [4, 9].
Hence, all patients at a risk for developing hypovol-
emia, a narrowing of the LVOT, a small LV lumen,
tachycardia, LV hyperkinesia or exposure to catechol-
amine use may develop IVO.
It is therefore not surprising to see this phenomenon
in the ICU setting of sepsis, where an older patient
population, frequently bearing a background of chronic
hypertension and impaired relaxation, is subject to an
acute metabolic and hemodynamic challenge. Septic pa-
tients have high circulating catecholamine levels and
their intravascular volume is acutely lost to increased
permeability, leading to often severe hypovolemia. TheTable 3 Logistic regression analysis for 28-day mortality and
ICU mortality
28-day mortality ICU mortality
OR 95 % CI p value OR 95 % CI p value
SAPS II 1.06 1.04–1.08 0.001 1.06 1.04–1.09 0.001
Presence of IVO 2.23 1.08–4.58 0.03 3.77 1.77–8.03 0.001
CI confidence interval, IVO intraventricular obstruction, OR odds ratio, SAPS
Simplified Acute Physiology Scoretreatment instituted in sepsis also adds risk factors: vaso-
pressors used on hypovolemic patients and inotropes
both contribute to the hypercontractility, and the fre-
quent use of loop diuretics and sometimes even β-
agonists for the treatment of respiratory distress, are all
contributing factors to the development of intraventricu-
lar obstructive gradients. Moreover, it is an interesting
finding of this study that 100 % of the patients with an
IVO were already receiving one or more of these (aggra-
vating) therapies.
Hypovolemia and IVG
The results of this study corroborate the association be-
tween hypovolemia and the presence of an intraventricu-
lar gradient (LVOT or mid-ventricular) in septic patients,
as previously described in the literature in the setting of
other hypovolemic states, such as acute blood loss [5, 9].
Pseudo-LVH
It has been previously demonstrated that, in the setting of
decreased filling volumes and reduced end-diastolic diame-
ters, remodeling of LV walls can lead to pseudohypertrophy,
in which ventricular walls appear thickened but total ven-
tricular mass remains unchanged when measured by echo-
cardiography or cardiac magnetic resonance imaging [21,
22]. The findings of this study support this as: although
there was frequently an appearance of myocardial hyper-
trophy (thickened LV walls on two-dimensional echocardi-
ography along with the presence of the IVO), in two-thirds
of patients the end-diastolic LV area was reduced such that,
when myocardial mass was calculated, it actually turned out
to be normal - thus 80 % of the time the thickening per-
ceived on two-dimensional echocardiography was pseudo-
rather than real hypertrophy.
Therefore, in fluid-depleted patients with decreased end-
diastolic diameters, the observation of IVG and thickened
walls is more likely to signify hypovolemia rather than true
LVH.
Fluid responsiveness
The fact that the fluid responsiveness observed in this sam-
ple of patients with IVG on Doppler flow analysis was close
to 90 % constitutes good evidence for performing a fluid
challenge on septic shock patients with this echocardio-
graphic finding. Even patients who had no significant in-
crease in cardiac index but who improved their systolic
index can still be considered as being in a better overall
hemodynamic state since the same cardiac output is now
maintained at the expense of less tachycardia. This finding
goes along with the previously discussed ones to suggest
that the presence of an IVG in a hypotensive septic patient
is likely to signify quite severe hypovolemia. Understand-
ing this may be crucial to adequate patient management
and to prevent further fluid depletion and catecholamine
Chauvet et al. Critical Care  (2015) 19:262 Page 7 of 8administration in these patients due to a misinterpretation
of their hemodynamic and cardiac status.
Mortality
Morelli et al. [23] found a high mortality rate in patients
with hyperkinesias characterized by a heart rate higher
than 95 beats/minute. We may expect that among these
patients some may have small and hyperkinetic left ven-
tricles and LV obstruction, as in our study group. The
high mortality found in our study may therefore corrob-
orate the high mortality found by Morelli et al. This may
be, in part, explained by severe hypovolemia and severity
of the sepsis with severe vasodilatation, catecholamines
and then hyperkinesia of the left ventricle.
Study limitations
In this study we did not record echocardiographic imaging
in all patients with sepsis, leading to missing data. The
protocol in which fluid boluses are given and tracked in our
unit does, however, partially help make up for and overcome
these impediments, and allowed enough data to be collected
for a systematic analysis. A prospective clinical trial, includ-
ing all patients with septic shock with an echocardiographic
recording, would help further establish the parameters for
using this method as a formal predictor of fluid responsive-
ness and may confirm higher mortality of septic shock
patients with IVO. The high incidence of IVO may be dis-
cussed and may be overestimated because of an “inappropri-
ate” infusion of dobutamine and the fact that cardiac output
measurement by the Doppler technique could have been
overestimated in cases of IVO.
Conclusion
This study showed that IVO in the early phase of septic
shock is not rare (presenting in over a quarter of septic
shock patients) and is associated with a high mortality
rate.
Our results warrant caution in the clinical interpret-
ation of LV thickening observed in the setting of hypo-
volemia and sepsis and support considering the likely
possibility of pseudohypertrophy when faced with a
small and hypercontractile left ventricle.
The high degree of fluid responsiveness noted in these
patients justifies considering a fluid challenge for septic
patients with IVO as well as parsimony in the adminis-
tration of inotropic amines and diuretics.
Key messages
 At the early phase of septic shock,
echocardiographic and Doppler left ventricular
obstruction is frequent
 Left ventricular obstruction is associated with
hypovolemia in septic shock patients Left ventricular obstruction is associated with a
high mortality rate.
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